Minimal uterine serous carcinoma: a clinicopathological study of 40 cases

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
Pei HuiP E Schwartz

Abstract

The term 'minimal uterine serous carcinoma' has been proposed to include serous carcinomas with invasion limited to the endometrium (superficial serous carcinoma), and those without stromal invasion (intraepithelial serous carcinoma or endometrial intraepithelial carcinoma). Both lesions display similar cytological and immunohistochemical profiles of a typical invasive serous carcinoma with a high nuclear grade and an overexpression of mutant p53 protein. We studied the clinicopathologic features of 40 cases of minimal uterine serous carcinoma. All patients were postmenopausal and underwent hysterectomy and surgical staging procedures. There were nine cases of intraepithelial serous carcinoma and 31 cases of superficial serous carcinoma. Five intraepithelial serous carcinomas and 16 superficial serous carcinomas exclusively involved an endometrial polyp. A total of 18 minimal uterine serous carcinomas also involved, in addition to a polyp, the endometrium proper in the form of intraepithelial serous carcinoma (13 cases) and superficial serous carcinoma (five cases). Overall, minimal uterine serous carcinomas were found to involve an endometrial polyp in 88% of the cases (35/40) and were confined to the polyp in 53% (21/40). Ext...Continue Reading

References

Apr 1, 1995·The American Journal of Surgical Pathology·G W Spiegel
Dec 31, 1997·The American Journal of Surgical Pathology·M L CarcangiuJ T Chambers
Mar 21, 1998·The American Journal of Surgical Pathology·D J BratR H Hruban
May 9, 2000·The American Journal of Surgical Pathology·R A SoslowC Isacson
Jun 8, 2000·The American Journal of Surgical Pathology·D T WheelerM E Sherman
Jul 11, 2001·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·R N BaergenL H Ellenson

❮ Previous
Next ❯

Citations

May 17, 2011·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Rochelle A SimonC James Sung
Jul 29, 2006·Journal of Clinical Pathology·W G McCluggage
Feb 19, 2013·Diagnostic Pathology·Masanori YasudaYoichi Kameda
Jul 17, 2008·Vojnosanitetski pregled. Military-medical and pharmaceutical review
Mar 1, 2014·Archives of Pathology & Laboratory Medicine·Natalia BuzaAlessandro D Santin
Sep 16, 2011·ISRN Obstetrics and Gynecology·Laurie ElitWaldo Jimenez
Nov 11, 2014·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·M Yang, B Assylbekova
Dec 26, 2013·Clinical Genitourinary Cancer·Giovanna GiordanoRoberto Berretta
Jan 2, 2013·Annals of Diagnostic Pathology·Romana IdreesNaila Kayani
Mar 1, 2011·Surgical Pathology Clinics·Esther Oliva, Robert A Soslow
Feb 12, 2011·Seminars in Diagnostic Pathology·W Glenn McCluggage
Feb 12, 2011·Seminars in Diagnostic Pathology·Diana Lim, Esther Oliva
Dec 31, 2015·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Robert A Soslow
Oct 2, 2015·Gynecologic Oncology Reports·Deepa M NarasimhuluYiquing Xu
Jul 23, 2008·Gynecologic Oncology·Alexander B OlawaiyeMarcela G del Carmen
Mar 24, 2009·Cancer·Amanda Nickles FaderUNKNOWN Uterine Papillary Serous Carcinoma (UPSC) Consortium
Jun 15, 2007·BJOG : an International Journal of Obstetrics and Gynaecology·P KellyW G McCluggage
Jun 15, 2007·Cytopathology : Official Journal of the British Society for Clinical Cytology·A M BuccolieroG L Taddei
Dec 20, 2011·The Journal of Obstetrics and Gynaecology Research·Shoji KakuTakafumi Nakamura
Mar 17, 2007·Pathology·Jaime PratLluis Catasús
Mar 17, 2007·Pathology·Joseph T Rabban, Charles J Zaloudek
Dec 19, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Taiebeh KafshdoozHamideh Alizadeh
Sep 25, 2012·Gynecologic Oncology·Marcela G del CarmenJohn O Schorge
Jul 14, 2009·Gynecologic Oncology·David M BorutaAlexander B Olawaiye
Jun 14, 2014·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Lin JiaWenxin Zheng
Feb 2, 2018·International Journal of Cancer. Journal International Du Cancer·Henrik FalconerDaniel Altman
Sep 26, 2017·Advances in Anatomic Pathology·Oluwole FadareVighnesh Walavalkar
Feb 9, 2018·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Chensi OuyangJune Y Hou
May 25, 2011·Journal of Gynecologic Oncology·Kouichiro KawanoToshiharu Kamura
Dec 20, 2017·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Oluwole FadareVinita Parkash
Jul 29, 2016·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Rita LuzTim Mould
Oct 21, 2016·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Gokhan BoyrazKunter Yuce
Jan 13, 2012·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Whitfield B GrowdonMarcela G del Carmen
Jan 26, 2012·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Shelly SewardSudeshna Bandyopadhyay
Mar 26, 2011·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Divya GuptaGloria S Huang
Sep 15, 2012·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Angiolo GadducciEnrico Sartori

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved